C1QBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.058600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.755400E-01
Normal-vs-Stage2
6.829400E-01
Normal-vs-Stage3
2.341000E-01
Normal-vs-Stage4
1.284430E-01
Stage1-vs-Stage2
4.448200E-01
Stage1-vs-Stage3
1.792570E-01
Stage1-vs-Stage4
2.076800E-01
Stage2-vs-Stage3
3.545200E-01
Stage2-vs-Stage4
5.516600E-01
Stage3-vs-Stage4
7.389000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.943400E-01
Normal-vs-AfricanAmerican
5.830800E-01
Normal-vs-Asian
9.318600E-01
Caucasian-vs-AfricanAmerican
1.319960E-01
Caucasian-vs-Asian
7.822400E-01
AfricanAmerican-vs-Asian
6.189400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.642000E-01
Normal-vs-Female
9.421400E-01
Male-vs-Female
2.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.381600E-01
Normal-vs-Age(41-60Yrs)
9.546600E-01
Normal-vs-Age(61-80Yrs)
5.790000E-01
Normal-vs-Age(81-100Yrs)
7.592600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.567000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.797400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.889200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.105900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.325600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.032200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.548000E-01
Normal-vs-Daily Drinker
3.983000E-01
Normal-vs-Weekly Drinker
8.129400E-01
Normal-vs-Occasional Drinker
6.903400E-01
Normal-vs-Social Drinker
6.234000E-01
Non Drinker-vs-Daily Drinker
8.436200E-01
Non Drinker-vs-Weekly Drinker
4.606400E-01
Non Drinker-vs-Occasional Drinker
7.028200E-01
Non Drinker-vs-Social Drinker
7.802400E-01
Daily Drinker-vs-Weekly Drinker
3.969000E-01
Daily Drinker-vs-Occasional Drinker
4.721000E-01
Daily Drinker-vs-Social Drinker
5.480800E-01
Weekly Drinker-vs-Occasional Drinker
5.820800E-01
Weekly Drinker-vs-Social Drinker
5.519400E-01
Occasional Drinker-vs-Social Drinker
9.198800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.967200E-01
Normal-vs-Grade 2
6.401000E-01
Normal-vs-Grade 3
6.391000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.129900E-02
Grade 1-vs-Grade 3
4.910300E-02
Grade 1-vs-Grade 4
6.967200E-01
Grade 2-vs-Grade 3
9.462000E-01
Grade 2-vs-Grade 4
6.401000E-01
Grade 3-vs-Grade 4
6.391000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.154600E-01
Normal-vs-NonDiabetic
8.652000E-01
Diabetic-vs-NonDiabetic
1.236980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.371400E-01
Normal-vs-NoPancreatitis
7.922400E-01
Pancreatitis-vs-NoPancreatitis
7.823600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.226000E-01
Normal-vs-N1
6.074200E-01
N0-vs-N1
2.365700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.955600E-01
Normal-vs-TP53-NonMutant
6.533400E-01
TP53-Mutant-vs-TP53-NonMutant
1.356150E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
